Morgan Stanley has adjusted its ratings on several healthcare companies ahead of the upcoming reporting season. Ramsay Health ...

These shares have the types of qualities that you want from long-term investments. The post The ASX blue chip shares I'd ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...

The table inside ranks the 20 biggest percentage winners and losers among stocks in the ASX300 at the end of each trading day ...

The S&P 500 inched upward in New York trading, recovering from earlier losses as oil, gold, and silver prices increased amid ...

ResMed's (NYSE:RMD) stock up by 3.2% over the past month. Given that the market rewards strong financials in the long-term, we wonder if that is the case in this instance. Particularly, we will be ...

ResMed CEO Mick Farrell has become the first leader from the home care sector to chair the board of directors at AdvaMed, the trade association representing major medtech companies.

Michael “Mick” Farrell, chairman and CEO of Resmed, has begun his two-year term as the new chair of AdvaMed’s board of ...

AdvaMed CEO Scott Whitaker and Mick Farrell, new board chair of the trade group, weighed in on important issues for the medtech industry one year into the Trump administration.

ResMed (RMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming ...

AdvaMed CEO Scott Whitaker and new AdvaMed Chair Mick Farrell discussed the MDUFA VI negotiations, FDA performance, tariffs ...

Detailed price information for Telix Pharmaceutical Ltd (TLPPF) from The Globe and Mail including charting and trades.